Walgreens Boots Alliance's healthcare unit reported $1.6 billion in revenue as the retail pharmacy giant turns toward primary care and healthcare.
Overall, the company's quarterly profit fell 20 percent, largely driven by a decline in demand for COVID-19 vaccines. The company's revenue still beat analysts' expectations, CNBC reported March 28.
During the quarter, sales at its VillageMD primary care business unit grew by 30 percent and sales at home care unit CareCentrix saw a 25 percent jump, according to a March 28 Walgreens news release.
"Walgreens Boots Alliance exited a solid second quarter with acceleration in February, adding to our confidence in driving strong growth in the second half of the year," Walgreens Boots Alliance CEO Rosalind Brewer said in the release. "With the closing of VillageMD's acquisition of Summit Health, WBA is now one of the largest players in primary care, with best-in-class assets across the care continuum. Both Walgreens and Boots are performing well by delivering compelling value to consumers, playing a critical role as community health destinations, and successfully navigating a challenging environment. We will continue to take bold actions to create sustainable long-term shareholder value."